Revolution Medicines stock hits all-time high at 208.77 USD
stock reached an all-time high of 208.77 USD, marking a significant milestone for the company. The stock currently trades at $208.48, giving the biotech firm a market capitalization of $44.48 billion, with shares hovering within 1% of their 52-week high.
Reported by 1 outlet — Investing.com · Company News. See all sources ↓
stock reached an all-time high of 208.77 USD, marking a significant milestone for the company. The stock currently trades at $208.48, giving the biotech firm a market capitalization of $44.48 billion, with shares hovering within 1% of their 52-week high. Over the past year, the stock has experienced a remarkable increase of 468.97%, reflecting strong investor confidence and interest in the company’s potential. The momentum extends across multiple timeframes, with year-to-date gains of 156% and a six-month surge of 102%.
Read the full report at Investing.com · Company News ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- stock reached an all-time high of 208.77 USD, marking a significant milestone for the company. The stock currently trades at $208.48, giving the biotech firm a market capitalization of $44.48 billion, with shares hovering within 1% of their 52-week high.
- How widely is it covered?
- 1 outlet, average source rating 5.0/10.
- When was it last updated?
- just now ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Revolution Medicines stock hits all-time high at 208.77 USD
Sources1TypeCoverageInvesting.com · Company News